Literature DB >> 32716356

Circulating Plasma Metabolites and Cognitive Function in a Puerto Rican Cohort.

Natalia Palacios1,2,3, Jong Soo Lee4, Tammy Scott5, Rachel S Kelly6, Shilpa N Bhupathiraju2,6, Sherman J Bigornia7, Katherine L Tucker8.   

Abstract

BACKGROUND: Minorities, including mainland Puerto Ricans, are impacted disproportionally by Alzheimer's disease (AD), dementia, and cognitive decline. Studying blood metabolomics in this population has the potential to probe the biological underpinnings of this health disparity.
OBJECTIVE: We performed a comprehensive analysis of circulating plasma metabolites in relation to cognitive function in 736 participants from the Boston Puerto Rican Health Study (BPRHS) who underwent untargeted mass-spectrometry based metabolomics analysis and had undergone a battery of in-person cognitive testing at baseline.
METHODS: After relevant exclusions, 621 metabolites were examined. We used multivariable regression, adjusted for age, sex, education, apolipoprotein E genotype, smoking, and Mediterranean dietary pattern, to identify metabolites related to global cognitive function in our cohort. LASSO machine learning was used in a complementary analysis to identify metabolites that could discriminate good from poor extremes of cognition. We also conducted sensitivity analyses: restricted to participants without diabetes, and to participants with good adherence to Mediterranean diet.
RESULTS: Of 621 metabolites, FDR corrected (p < 0.05) multivariable linear regression identified 3 metabolites positively, and 10 negatively, associated with cognitive function in the BPRHS. In a combination of FDR-corrected linear regression, logistic regression regularized via LASSO, and sensitivity analyses restricted to participants without diabetes, and with good adherence to the Mediterranean diet, β-cryptoxanthin plasma concentration was consistently associated with better cognitive function and N-acetylisoleucine and tyramine O-sulfate concentrations were consistently associated with worse cognitive function.
CONCLUSION: This untargeted metabolomics study identified potential biomarkers for cognitive function in a cohort of Puerto Rican older adults.

Entities:  

Keywords:  Cognitive function; Puerto Ricans; diabetes; metabolomics

Year:  2020        PMID: 32716356      PMCID: PMC8061579          DOI: 10.3233/JAD-200040

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  54 in total

1.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician.

Authors:  M F Folstein; S E Folstein; P R McHugh
Journal:  J Psychiatr Res       Date:  1975-11       Impact factor: 4.791

2.  Association of metabolic syndrome with Alzheimer disease: a population-based study.

Authors:  M Vanhanen; K Koivisto; L Moilanen; E L Helkala; T Hänninen; H Soininen; K Kervinen; Y A Kesäniemi; M Laakso; J Kuusisto
Journal:  Neurology       Date:  2006-09-12       Impact factor: 9.910

3.  Stress and nutrition in relation to excess development of chronic disease in Puerto Rican adults living in the Northeastern USA.

Authors:  Katherine L Tucker
Journal:  J Med Invest       Date:  2005-11

Review 4.  Potential Impact and Study Considerations of Metabolomics in Cardiovascular Health and Disease: A Scientific Statement From the American Heart Association.

Authors:  Susan Cheng; Svati H Shah; Elizabeth J Corwin; Oliver Fiehn; Robert L Fitzgerald; Robert E Gerszten; Thomas Illig; Eugene P Rhee; Pothur R Srinivas; Thomas J Wang; Mohit Jain
Journal:  Circ Cardiovasc Genet       Date:  2017-04

5.  Applications of Metabolomics in the Study and Management of Preeclampsia; A Review of the Literature.

Authors:  Rachel S Kelly; Rachel T Giorgio; Bo L Chawes; Natalia I Palacios; Kathryn J Gray; Hoooman Mirzakhani; Ann Wu; Kevin Blighe; Scott T Weiss; Jessica Lasky-Su
Journal:  Metabolomics       Date:  2017-06-12       Impact factor: 4.290

6.  Assessment of Racial Disparities in Biomarkers for Alzheimer Disease.

Authors:  John C Morris; Suzanne E Schindler; Lena M McCue; Krista L Moulder; Tammie L S Benzinger; Carlos Cruchaga; Anne M Fagan; Elizabeth Grant; Brian A Gordon; David M Holtzman; Chengjie Xiong
Journal:  JAMA Neurol       Date:  2019-03-01       Impact factor: 18.302

7.  Metabolomic markers of healthy dietary patterns in US postmenopausal women.

Authors:  Marjorie L McCullough; Maret L Maliniak; Victoria L Stevens; Brian D Carter; Rebecca A Hodge; Ying Wang
Journal:  Am J Clin Nutr       Date:  2019-05-01       Impact factor: 7.045

Review 8.  Absorption, metabolism, and functions of β-cryptoxanthin.

Authors:  Betty J Burri; Michael R La Frano; Chenghao Zhu
Journal:  Nutr Rev       Date:  2016-01-07       Impact factor: 7.110

9.  Dietary intake of branched-chain amino acids in a mouse model of Alzheimer's disease: Effects on survival, behavior, and neuropathology.

Authors:  Marine Tournissac; Milene Vandal; Cyntia Tremblay; Philippe Bourassa; Sylvie Vancassel; Vincent Emond; Anne Gangloff; Frederic Calon
Journal:  Alzheimers Dement (N Y)       Date:  2018-12-10

10.  The Mediterranean, Dietary Approaches to Stop Hypertension (DASH), and Mediterranean-DASH Intervention for Neurodegenerative Delay (MIND) Diets Are Associated with Less Cognitive Decline and a Lower Risk of Alzheimer's Disease-A Review.

Authors:  Annelien C van den Brink; Elske M Brouwer-Brolsma; Agnes A M Berendsen; Ondine van de Rest
Journal:  Adv Nutr       Date:  2019-11-01       Impact factor: 8.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.